Curcuminoid Compounds

About Avidin

Avidin is a diversified biotech firm with a dual focus on therapeutic discovery and molecular diagnostics. Its most advanced program is Q134R, a clinical candidate for Alzheimer's disease developed in partnership with Aperus Pharma. The company also maintains active research in oncology and inflammation, and provides preclinical services and diagnostic products, supported by international scientific and industrial collaborations.

Therapeutic Areas